top of page
Competition
NO OTHER CANCER DRUG WORKS IN THE SAME WAY AS ONKONEK
The specific structure of the highly unusual ONKONEK warhead is protected by patent GB 258257 now in PCT phases in the USA and Europe and by a recently filed new patent.
ONKONEK’s specifically designed structure makes it unlikely that random chemicals historically held in banks by drug companies or newly created by AI would come up with similar competing molecules.
ONKONEK’s global therapeutic range and lack of normal tissue toxicity are likely to out-compete any presently available agent.
bottom of page